Amundi Asset Management US’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,000
Closed -$94K 1643
2018
Q3
$94K Buy
2,000
+900
+82% +$42.3K ﹤0.01% 1479
2018
Q2
$55K Hold
1,100
﹤0.01% 1512
2018
Q1
$55K Hold
1,100
﹤0.01% 1483
2017
Q4
$41K Buy
+1,100
New +$41K ﹤0.01% 1508